These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29579038)

  • 1. Results of a confirmatory mapping tool for Lymphatic filariasis endemicity classification in areas where transmission was uncertain in Ethiopia.
    Sime H; Gass KM; Mekasha S; Assefa A; Woyessa A; Shafi O; Meribo K; Kebede B; Ogoussan K; Pelletreau S; Bockarie MJ; Kebede A; Rebollo MP
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006325. PubMed ID: 29579038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How Thailand eliminated lymphatic filariasis as a public health problem.
    Rojanapanus S; Toothong T; Boondej P; Thammapalo S; Khuanyoung N; Santabutr W; Prempree P; Gopinath D; Ramaiah KD
    Infect Dis Poverty; 2019 May; 8(1):38. PubMed ID: 31130143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shrinking the Lymphatic Filariasis Map of Ethiopia: Reassessing the Population at Risk through Nationwide Mapping.
    Rebollo MP; Sime H; Assefa A; Cano J; Deribe K; Gonzalez-Escalada A; Shafi O; Davey G; Brooker SJ; Kebede A; Bockarie MJ
    PLoS Negl Trop Dis; 2015 Nov; 9(11):e0004172. PubMed ID: 26539700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The rationale and cost-effectiveness of a confirmatory mapping tool for lymphatic filariasis: Examples from Ethiopia and Tanzania.
    Gass KM; Sime H; Mwingira UJ; Nshala A; Chikawe M; Pelletreau S; Barbre KA; Deming MS; Rebollo MP
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0005944. PubMed ID: 28976981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying residual transmission of lymphatic filariasis after mass drug administration: Comparing school-based versus community-based surveillance - American Samoa, 2016.
    Sheel M; Sheridan S; Gass K; Won K; Fuimaono S; Kirk M; Gonzales A; Hedtke SM; Graves PM; Lau CL
    PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006583. PubMed ID: 30011276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is mass drug administration against lymphatic filariasis required in urban settings? The experience in Kano, Nigeria.
    Pam DD; de Souza DK; D'Souza S; Opoku M; Sanda S; Nazaradden I; Anagbogu IN; Okoronkwo C; Davies E; Elhassan E; Molyneux DH; Bockarie MJ; Koudou BG
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006004. PubMed ID: 29020042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lymphatic filariasis transmission assessment survey in schools three years after stopping mass drug treatment with albendazole and ivermectin in the 7 endemic districts in Togo].
    Dorkenoo AM; Sodahlon YK; Bronzan RN; Yakpa K; Sossou E; Ouro-Medeli A; Teko M; Seim A; Mathieu E
    Bull Soc Pathol Exot; 2015 Aug; 108(3):181-7. PubMed ID: 25476256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Expanded Transmission Assessment Survey to Confirm the Interruption of Lymphatic Filariasis Transmission in Wallis and Futuna.
    Pezzoli L; Kim SH; Mathelin JP; Hennessey K; Eswara Aratchige P; Valiakolleri J
    Am J Trop Med Hyg; 2019 Dec; 101(6):1325-1330. PubMed ID: 31595868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of transmission in areas of uncertain endemicity for lymphatic filariasis in Brazil.
    Xavier A; Oliveira H; Aguiar-Santos A; Barbosa Júnior W; da Silva E; Braga C; Bonfim C; Medeiros Z
    PLoS Negl Trop Dis; 2019 Nov; 13(11):e0007836. PubMed ID: 31765388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First evidence of lymphatic filariasis transmission interruption in Cameroon: Progress towards elimination.
    Nana-Djeunga HC; Tchouakui M; Njitchouang GR; Tchatchueng-Mbougua JB; Nwane P; Domche A; Bopda J; Mbickmen-Tchana S; Akame J; Tarini A; Epée E; Biholong BD; Zhang Y; Tougoue JJ; Kabore A; Njiokou F; Kamgno J
    PLoS Negl Trop Dis; 2017 Jun; 11(6):e0005633. PubMed ID: 28662054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The National Programme to Eliminate Lymphatic Filariasis from Ethiopia.
    Mengistu B; Deribe K; Kebede F; Martindale S; Hassan M; Sime H; Mackenzie C; Mulugeta A; Tamiru M; Sileshi M; Hailu A; Gebre T; Fentaye A; Kebede B
    Ethiop Med J; 2017; 55(Suppl 1):45-54. PubMed ID: 28878429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic sampling of adults as a sensitive means of detecting persistence of lymphatic filariasis following mass drug administration in Sri Lanka.
    Rao RU; Samarasekera SD; Nagodavithana KC; Punchihewa MW; Ranasinghe USB; Weil GJ
    PLoS Negl Trop Dis; 2019 Apr; 13(4):e0007365. PubMed ID: 31009482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of annual single doses of diethylcarbamazine citrate among bancroftian filariasis infected individuals in an endemic area under mass drug administration in Brazil.
    da Silva JSF; Braga C; Duarte FM; Oliveira P; Feitosa Luna C; Marcondes M; Araújo J; Grilis MR; de Souza Melo PFA; Brandão E; Rocha A
    Pathog Glob Health; 2018 Jul; 112(5):274-280. PubMed ID: 30111259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mini-TAS as a confirmatory mapping tool for remapping areas with uncertain filarial endemicity to exclude/ include for mass drug administration: A report from field validation in India.
    Panda BB; Krishnamoorthy K; Das A; Jain HK; Dixit S; Rahi M; Somalkar N; Mohanty S; Pati S; Ranjit M; Bal M
    PLoS One; 2023; 18(11):e0293641. PubMed ID: 37922274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive assessment of lymphatic filariasis in Sri Lanka six years after cessation of mass drug administration.
    Rao RU; Nagodavithana KC; Samarasekera SD; Wijegunawardana AD; Premakumara WD; Perera SN; Settinayake S; Miller JP; Weil GJ
    PLoS Negl Trop Dis; 2014; 8(11):e3281. PubMed ID: 25393404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphatic filariasis control in Tanzania: infection, disease perceptions and drug uptake patterns in an endemic community after multiple rounds of mass drug administration.
    Derua YA; Kisinza WN; Simonsen PE
    Parasit Vectors; 2018 Jul; 11(1):429. PubMed ID: 30029675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significant scale up and success of Transmission Assessment Surveys 'TAS' for endgame surveillance of lymphatic filariasis in Bangladesh: One step closer to the elimination goal of 2020.
    Shamsuzzaman AK; Haq R; Karim MJ; Azad MB; Mahmood AS; Khair A; Rahman MM; Hafiz I; Ramaiah KD; Mackenzie CD; Mableson HE; Kelly-Hope LA
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005340. PubMed ID: 28141812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphatic filariasis transmission risk map of India, based on a geo-environmental risk model.
    Sabesan S; Raju KH; Subramanian S; Srivastava PK; Jambulingam P
    Vector Borne Zoonotic Dis; 2013 Sep; 13(9):657-65. PubMed ID: 23808973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of sensitivity of immunochromatographic test (ICT) for lymphatic filariasis diagnosis in low prevalence settings: consequence in the monitoring and evaluation procedures.
    Gounoue-Kamkumo R; Nana-Djeunga HC; Bopda J; Akame J; Tarini A; Kamgno J
    BMC Infect Dis; 2015 Dec; 15():579. PubMed ID: 26700472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A surveillance system for lymphatic filariasis after its elimination in Sri Lanka.
    Rahman MA; Yahathugoda TC; Tojo B; Premaratne P; Nagaoka F; Takagi H; Kannathasan S; Murugananthan A; Weerasooriya MV; Itoh M
    Parasitol Int; 2019 Feb; 68(1):73-78. PubMed ID: 30308253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.